Drug Discovery |
Disease Models |
AACR |
Cancer Research
What You Missed at AACR 2026: Five Takeaways From San Diego That Could Change Your Cell Lineup
A field report from the EditCo team
Read More
Drug Discovery |
Science Policy
The Shaking of the Scientific Bedrock
This Monday, the American Association for Cancer Research (AACR) came out with a formal statement regarding the recent actions of the new...
Read More
Target Identification |
Drug Discovery |
XDel
CRISPR and AI in Drug Discovery: Finding the Needle in the Genomic Haystack
Over the past decade, CRISPR gene-editing technology and artificial intelligence (AI) have emerged as transformative forces in biomedical research....
Read More
Drug Discovery |
Disease Models |
Science Policy
The Crucial Role of Female-Derived Cell Models in Biomedical Research
For many years, female donor-derived cells were significantly underrepresented in preclinical studies, impacting both medical treatment development...
Read More
Target Identification |
CRISPR Screening |
Drug Discovery
Pooled Versus Arrayed Screens: Considerations Before Choosing a Screening Format
Introduction The drug discovery process begins with identifying genes or targets that play a role in the specific disease of interest. This critical...
Read More